Viking Global Reports 6.4% Stake in BioMarin (BMRN) — 12.29M Shares
Viking Global and affiliated funds report a 6.4% common-stock stake in BioMarin Pharmaceuticals (BMRN).
Rhea-AI Filing Summary
Viking Global and affiliated funds report a 6.4% common-stock stake in BioMarin Pharmaceuticals (BMRN). Collectively the Reporting Persons beneficially own 12,288,611 shares out of 192,001,650 shares outstanding as of June 30, 2025. Ownership is shared (no reported sole voting or dispositive power); the holdings are held across several Viking entities and funds (largest positions reported: Viking Global Investors LP 12,288,611; Viking Global Performance LLC 8,208,825; Viking Global Equities Master Ltd. 8,044,650; Viking Long Fund Master Ltd. 2,856,671; Viking Global Opportunities Liquid Portfolio Sub-Master LP 1,223,115). The filing states the securities were not acquired to change or influence control of the issuer. Signatures on the amendment are dated August 14, 2025.
Positive
- Material ownership disclosed: Reporting Persons collectively report 12,288,611 shares, equal to 6.4% of outstanding common stock, improving market transparency.
- Structured disclosure across entities: The filing breaks down holdings by each Viking entity and names involved individuals, clarifying allocation of shared voting and dispositive power.
- Certification of passive intent: Reporting Persons certify the securities were not acquired to change or influence control, indicating no announced activism.
Negative
- None.
Insights
TL;DR A coordinated disclosure shows Viking-affiliated entities hold a material 6.4% stake in BioMarin, reported as shared beneficial ownership.
The filing documents that multiple Viking funds and management-affiliated individuals may be deemed beneficial owners of 12,288,611 BioMarin shares, representing 6.4% of the reported outstanding common stock (192,001,650). The ownership is recorded as shared voting and dispositive power across entities rather than sole control. The filing includes the required joint-filing agreement and a certification that the position is not intended to influence control. For investors, this is a material ownership disclosure that increases transparency about a sizable passive position but contains no statements of intent or plans that would indicate an active campaign or control attempt.
TL;DR Material passive stake disclosed; no sole voting/dispositive power and no stated intent to exert control.
The Schedule 13G/A shows Viking-affiliated reporting persons and three Executive Committee members may be deemed to beneficially own the same 12,288,611 shares. All reported holdings are identified as shared voting and shared dispositive power; each named individual reports no sole authority. The filing includes the standard certification that the shares were not acquired to change or influence issuer control. From a governance perspective, this disclosure clarifies potential influence channels but does not indicate an active governance campaign or change in board/control intentions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was the stake acquired to influence control of BioMarin?
Which Viking entities hold the largest reported BioMarin positions?
AI-generated analysis. How Rhea-AI works. Not financial advice.